Scott Woods

ProCAN: Psychosis Risk Outcomes Compound Assessment Network

National Institute of Mental Health · U01

Contact PI · $48.7M · Yale University

ProNET: Psychosis-Risk Outcomes Network

National Institute of Mental Health · U01

Contact PI · $78.3M · Yale University

DDT-COA-000-163 Accelerating the FDA COA Qualification Package for thePSYCHS as a ClinRO Measure

Food and Drug Administration · U01

PI · $250K · Yale University

5/5 CAPER: Computerized Assessment of Psychosis Risk

National Institute of Mental Health · R01

PI · $3.1M · Yale University

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Principal investigator · Recruiting · Phase 1, Phase 2

Monument Therapeutics Limited

AMP SCZ® Observational Study: PREDICT-DPACC

Principal investigator · Active not recruiting

Brigham and Women's Hospital

Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial

Principal investigator · Active not recruiting

University of California, Los Angeles

Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Principal investigator · Terminated · Early phase 1

Yale University